ILEVRO (nepafenac) suspension/ drops [Harrow Eye, LLC]

03 Apr 20264 min read0 viewsVerified Feed

GIST

DailyMed Drug Label Updates published a clinical update in Pharmacology on 03 Apr 2026. The item focuses on ILEVRO (nepafenac) suspension/ drops [Harrow Eye, LLC]. Review the original article for the full source wording and details.

Clinical Editorial

Summary

DailyMed Drug Label Updates published a clinical update in Pharmacology on 03 Apr 2026.

The item focuses on ILEVRO (nepafenac) suspension/ drops [Harrow Eye, LLC].

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

BMJRelated by Specialty

BUPROPION HYDROCHLORIDE XL (bupropion hydrochloride) tablet, extended release [Lupin Pharmaceuticals, Inc.]

Pharmacology • 23 Apr 2026

Feed Metadata

Source

DailyMed Drug Label Updates

ILEVRO (nepafenac) suspension/ drops [Harrow Eye, LLC]

GIST

Clinical Editorial

Summary

Source Reference

Related by Condition/Drug

FDA Blocks Publication Of Studies On Covid-19 And Shingles Vaccines

MGC HEALTH: Class II recall update

FHF Farmhouse Fresh: Class II recall update

ALVIMOPAN capsule [Par Health USA, LLC]

BUPROPION HYDROCHLORIDE XL (bupropion hydrochloride) tablet, extended release [Lupin Pharmaceuticals, Inc.]